Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer's Disease.

Vidal, Verónica; Puente, Alba; García-Cerro, Susana; García Unzueta, María Teresa; Rueda, Noemí; Riancho, Javier; Martínez-Cué, Carmen

Vidal, Verónica; Puente, Alba; García-Cerro, Susana; García Unzueta, María Teresa; Rueda, Noemí; Riancho, Javier; Martínez-Cué, Carmen.

Afiliación

Vidal V; Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander, Spain.
Puente A; Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander, Spain.
García-Cerro S; Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander, Spain.
García Unzueta MT; CIBERSAM, Madrid, Spain.
Rueda N; Department of Clinical Biochemistry, University Hospital Marques de Valdecilla-IDIVAL, Santander, Spain.
Riancho J; Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander, Spain.
Martínez-Cué C; Neurology Service, Hospital Sierrallana-IDIVAL, Torrelavega, Spain.

Front Pharmacol ; 12: 613211, 2021.

Article en En | MEDLINE | ID: mdl-33935706

Palabras clave

Alzheheimer's disease; Down syndrome; bexarotene; cognition; hypothyroidism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google